Skip to Content

International Lymphoma Epidemiology Consortium (InterLymph)

The goal of the International Lymphoma Epidemiology Consortium (InterLymph) is to enhance collaboration among epidemiologists studying lymphoma, provide a forum for the exchange of research ideas, and create a framework for collaborating on analyses that pool data from multiple studies. Within the consortium, DCEG investigators are currently leading pooled analyses to 1) investigate whether the risk of non-Hodgkin lymphoma associated with cigarette smoking and personal hair dye use is modified by genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), which encode enzymes that metabolize aromatic and heterocyclic amines, and 2) provide the first comprehensive assessments of risk factors for several rare lymphoma subtypes.

For more information, refer to the InterLymph website (http://epi.grants.cancer.gov/InterLymph/).